EP Patent

EP2420503A1 — Process for the synthesis of 14-oxygenated morphinan-6-ones

Assigned to Universitaet Innsbruck · Expires 2012-02-22 · 14y expired

What this patent protects

A process for the production of 14-oxygenated morphinan-6-ones wherein a methylether group in position 3 of the phenyl ring which has to be cleaved to obtain the hydroxy group, and wherein the protection of the hydroxy group in position 3 of the phenyl ring in the presence of a k…

USPTO Abstract

A process for the production of 14-oxygenated morphinan-6-ones wherein a methylether group in position 3 of the phenyl ring which has to be cleaved to obtain the hydroxy group, and wherein the protection of the hydroxy group in position 3 of the phenyl ring in the presence of a ketal group is avoided.

Drugs covered by this patent

Patent Metadata

Patent number
EP2420503A1
Jurisdiction
EP
Classification
Expires
2012-02-22
Drug substance claim
No
Drug product claim
No
Assignee
Universitaet Innsbruck
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.